10X Genomics Inc (TXG) Stock Price, Quote & News

Company Profile

10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; and QuantumScale single cell RNA and singl...

Industry: Health Information Services

Sector: Healthcare

Phone: 925 401 7300

Website: www.10xgenomics.com

Address:

6230 Stoneridge Mall Road, Pleasanton, United States

WAJeff Jul. 1 at 8:05 PM

$TXG Sold this at a breakeven like a dummy. It went past that $36 target in my earlier post

0 · Reply

WAJeff Jul. 1 at 8:04 PM

$TXG been on a tear

0 · Reply

WOLFSTREET Jul. 1 at 1:27 AM

$TXG soon, you too can enjoy the entire platform like I do. for now, let me break down what matters most.

0 · Reply

WOLFSTREET Jul. 1 at 1:26 AM

$TXG 215% in 1 YEAR, how da ya luv that? Oh yeah, that was early CC version of experiments on the front-end, all gone now, CC9.8 format is all that is needed and I show it off regularly. That was CC9.1 last year, so CC wen thru 8 development cycles in just 1 year!

0 · Reply

WOLFSTREET Jul. 1 at 1:19 AM

$TXG $RACE TXG 40% straight UP from this post, you only need to be in one place to perform like this, and that is @WOLFSTREET , on my street, where CC rules to roads.

0 · Reply

strassburg Jun. 28 at 2:42 AM

$TXG I love this stock for the future. Slow build

0 · Reply

itrekntravel Jun. 26 at 7:54 PM

$TXG pop goes my TXG! 💥

0 · Reply

egcgfiend Jun. 26 at 2:05 PM

$PACB $TXG $ILMN AI + genomics = cure all disease and aging

0 · Reply

WalterWhite13 Jun. 24 at 4:21 PM

$TXG the ATERA platform will dominate everything spacial. The Platform does more and is better than the marketing team is saying. This will be up by $80 by end of year.

3 · Reply

MikeCaymanTrades Jun. 21 at 12:55 AM

$TXG - Massive broadening wedge from last April. 6.78 to 34.76

0 · Reply

10x Genomics price target raised to $40 from $30 at Barclays

Jun 17, 2026, 5:00 PM EDT - 16 days ago

Torex Gold Announces Results of Its 2026 Meeting of Shareholders

2026-06-17T13:07:30.000Z - 17 days ago

10x Genomics announces research collaboration with Cleveland Clinic

Jun 17, 2026, 9:00 AM EDT - 17 days ago

10x Genomics and Cleveland Clinic Collaborate to Advance Research in Diagnostic Applications of Single Cell and Spatial Technologies in Patients with Bladder Cancer

ADC

2026-06-09T13:11:53.000Z - 25 days ago

10x Genomics acquires Proteintech Genomics

Jun 9, 2026, 9:00 AM EDT - 25 days ago

10x Genomics Acquires Proteintech Genomics, a Division Within Proteintech Group

May 13, 2026, 8:00 PM EDT - 7 weeks ago

10x Genomics Transcript: Bank of America Global Healthcare Conference 2026

2026-05-12T15:27:11.000Z - 7 weeks ago

10x Genomics price target raised to $22 from $20 at Morgan Stanley

2026-05-12T12:26:29.000Z - 7 weeks ago

10x Genomics price target raised to $20 from $17 at JPMorgan

2026-05-08T16:10:27.000Z - 2 months ago

10x Genomics price target raised to $23 from $17 at Deutsche Bank

2026-05-07T21:30:11.000Z - 2 months ago

10x Genomics reports Q1 EPS (10c), consensus (6c)

2026-05-07T21:28:54.000Z - 2 months ago

10x Genomics backs FY26 revenue view $600M-$625M, consensus $612.74M

May 7, 2026, 4:30 PM EDT - 2 months ago

10x Genomics Earnings Call Transcript: Q1 2026

May 7, 2026, 4:30 PM EDT - 2 months ago

10x Genomics Earnings release: Q1 2026

May 7, 2026, 4:30 PM EDT - 2 months ago

10x Genomics Quarterly report: Q1 2026

May 7, 2026, 4:05 PM EDT - 2 months ago

10x Genomics Reports First Quarter 2026 Financial Results

Apr 29, 2026, 4:05 PM EDT - 2 months ago

10x Genomics to Participate in the BofA Securities 2026 Healthcare Conference

Apr 24, 2026, 8:00 AM EDT - 2 months ago

10x Genomics Proxy statement: Proxy filing

Apr 24, 2026, 8:00 AM EDT - 2 months ago

10x Genomics Proxy statement: Proxy filing

Apr 23, 2026, 7:00 AM EDT - 2 months ago

LiquidCell Dx Appoints Former Foundation Medicine, 10x Genomics and IDT Leader Mirna Jarosz as Chief Executive Officer; Names Former Foundation Medicine Chief Medical Officer Vincent A. Miller, MD, Senior Strategic Advisor

2026-04-20T14:03:59.000Z - 2 months ago

10x Genomics price target raised to $32 from $22 at Canaccord

2026-04-20T13:43:54.000Z - 2 months ago

10x Genomics price target raised to $30 from $21 at BofA

2026-04-19T17:10:44.000Z - 2 months ago

10x Genomics announces Atera, a new in situ spatial biology platform

Apr 18, 2026, 10:00 PM EDT - 2 months ago

10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood

Apr 17, 2026, 7:00 AM EDT - 2 months ago

10x Genomics Slides: Corporate presentation

Apr 15, 2026, 4:05 PM EDT - 2 months ago

10x Genomics to Report First Quarter 2026 Financial Results on May 7, 2026

2026-04-14T10:50:31.000Z - 2 months ago

10x Genomics price target raised to $30 from $22 at Barclays

2026-04-07T10:15:11.000Z - 3 months ago

10x Genomics price target raised to $24 from $18 at Citi

2026-03-30T21:45:11.000Z - 3 months ago

10x Genomics upgraded to Outperform from Market Perform at William Blair

Mar 25, 2026, 7:00 AM EDT - 3 months ago

Bioptimus Announces STELA: The World's Largest Clinically Linked Spatial Biology Atlas, alongside key partners 10x Genomics and Broad Clinical Labs

2026-03-20T00:20:12.000Z - 3 months ago

Cathie Wood’s ARK Investment buys 92K shares of 10x Genomics today

Mar 17, 2026, 8:00 AM EDT - 3 months ago

PerturbAI Launches from Stealth, Unveils the World's Largest In Vivo CRISPR Atlas

2026-03-16T16:06:47.000Z - 3 months ago

10x Genomics falls -13.8%

Mar 3, 2026, 11:50 AM EST - 4 months ago

10x Genomics Transcript: TD Cowen 46th Annual Health Care Conference

Feb 19, 2026, 4:05 PM EST - 4 months ago

10x Genomics to Participate in the 46th Annual TD Cowen Health Care Conference

Feb 12, 2026, 4:30 PM EST - 5 months ago

10x Genomics Earnings Call Transcript: Q4 2025

Feb 12, 2026, 4:30 PM EST - 5 months ago

10x Genomics Annual report: Q4 2025

Feb 12, 2026, 4:30 PM EST - 5 months ago

10x Genomics Earnings release: Q4 2025

Feb 12, 2026, 4:05 PM EST - 5 months ago

10x Genomics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Outlook for 2026

Feb 4, 2026, 9:00 AM EST - 5 months ago

PharosAI and 10x Genomics Partner to Transform Cancer Research with AI and Spatial Biology

Jan 22, 2026, 4:05 PM EST - 5 months ago

10x Genomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 12, 2026

Jan 12, 2026, 11:15 AM EST - 6 months ago

10x Genomics Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 11:15 AM EST - 6 months ago

10x Genomics Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 9:11 AM EST - 6 months ago

10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease

Jan 12, 2026, 9:10 AM EST - 6 months ago

10x Genomics to Advance Research in Diagnostic Applications of Tumor Single Cell and Spatial Profiling

Jan 12, 2026, 9:00 AM EST - 6 months ago

Cancer Research Institute Launches Transformative AI-Driven Immuno-Oncology Initiative Powered by 10x Genomics Technology

Jan 11, 2026, 12:00 PM EST - 6 months ago

10x Genomics Announces Preliminary Select Fourth Quarter and Full Year 2025 Results

Jan 7, 2026, 7:05 AM EST - 6 months ago

CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response

CDNA

Dec 29, 2025, 4:05 PM EST - 6 months ago

10x Genomics to Present at the 44th Annual J.P. Morgan Healthcare Conference

Nov 18, 2025, 11:20 AM EST - 8 months ago

10x Genomics Transcript: Wolfe Research Healthcare Conference 2025

Nov 18, 2025, 9:00 AM EST - 8 months ago

New ASTRA Consortium Unites Asia-Pacific Scientists to Build Pan-Cancer Spatial Atlas Powered by 10x Genomics' Xenium

Nov 11, 2025, 4:05 PM EST - 8 months ago

10x Genomics to Participate in the Wolfe Research Healthcare Conference 2025

Nov 6, 2025, 4:30 PM EST - 8 months ago

10x Genomics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:30 PM EST - 8 months ago

10x Genomics Quarterly report: Q3 2025

Nov 6, 2025, 4:30 PM EST - 8 months ago

10x Genomics Earnings release: Q3 2025

Nov 6, 2025, 4:05 PM EST - 8 months ago

10x Genomics Reports Third Quarter 2025 Financial Results

Oct 29, 2025, 9:00 AM EDT - 8 months ago

10x Genomics Launches the Next Generation of Chromium Flex to Empower Scientists to Massively Scale Single Cell Research

Oct 20, 2025, 12:30 PM EDT - 9 months ago

10x Genomics and Anthropic Partner to Make Single Cell and Spatial Analysis More Accessible Through Claude for Life Sciences

Oct 9, 2025, 4:05 PM EDT - 9 months ago

10x Genomics to Report Third Quarter 2025 Financial Results on November 6, 2025

Oct 9, 2025, 8:00 AM EDT - 9 months ago

Parse Biosciences Invalidates Scale Biosciences (now 10x Genomics) Patent

Sep 10, 2025, 11:30 AM EDT - 10 months ago

10x Genomics Transcript: Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 9, 2025, 9:00 AM EDT - 10 months ago

CLISEQ, 10X Genomics and Weizmann Institute to Investigate Single Cell Applications in Hematology Clinical Diagnostics

Aug 27, 2025, 4:05 PM EDT - 11 months ago

10x Genomics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Aug 19, 2025, 9:00 AM EDT - 11 months ago

10x Genomics Launches Xenium Protein, Advancing Spatial Biology by Enabling Same-Cell RNA and Protein Analysis

Aug 7, 2025, 4:30 PM EDT - 11 months ago

10x Genomics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 11 months ago

10x Genomics Quarterly report: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 11 months ago

10x Genomics Earnings release: Q2 2025

Aug 7, 2025, 4:05 PM EDT - 11 months ago

10x Genomics Reports Second Quarter 2025 Financial Results

Aug 7, 2025, 4:04 PM EDT - 11 months ago

10x Genomics to Acquire Scale Biosciences

Jul 17, 2025, 9:00 AM EDT - 1 year ago

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

Jul 10, 2025, 4:05 PM EDT - 1 year ago

10x Genomics to Report Second Quarter 2025 Financial Results on August 7, 2025

May 14, 2025, 4:05 PM EDT - 1 year ago

10x Genomics Announces Patent Litigation Settlement Agreement with Bruker

May 13, 2025, 2:20 PM EDT - 1 year ago

10x Genomics Transcript: Bank of America 2025 Healthcare Conference

May 8, 2025, 4:30 PM EDT - 1 year ago

10x Genomics Earnings Call Transcript: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

10x Genomics Quarterly report: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

10x Genomics Earnings release: Q1 2025

May 8, 2025, 4:05 PM EDT - 1 year ago

10x Genomics Reports First Quarter 2025 Financial Results

Apr 30, 2025, 4:05 PM EDT - 1 year ago

10x Genomics to Participate in the BofA Securities 2025 Healthcare Conference

Apr 15, 2025, 8:00 AM EDT - 1 year ago

10x Genomics Proxy statement: Proxy Filing

Apr 14, 2025, 8:00 AM EDT - 1 year ago

10x Genomics Proxy statement: Proxy Filing

Apr 3, 2025, 8:00 AM EDT - 1 year ago

Vizgen Announces End of Litigation with 10x Genomics and Harvard University

Mar 4, 2025, 11:10 AM EST - 1 year ago

10x Genomics Transcript: TD Cowen 45th Annual Healthcare Conference

Mar 3, 2025, 4:05 PM EST - 1 year ago

10x Genomics Secures Injunction Against Parse Biosciences' Planned ATAC Products

Feb 23, 2025, 11:30 AM EST - 1 year ago

10x Genomics Unveils Innovation Roadmap at AGBT General Meeting, Advancing Leadership in Large-Scale Single Cell and Spatial Analysis

Feb 18, 2025, 4:05 PM EST - 1 year ago

10x Genomics to Participate in the 45th Annual TD Cowen Health Care Conference

Feb 12, 2025, 7:19 PM EST - 1 year ago

Trump's Cuts to Medical Research Are Hurting These Stocks

ILMN PACB

Feb 12, 2025, 4:30 PM EST - 1 year ago

10x Genomics Earnings Call Transcript: Q4 2024

Feb 12, 2025, 4:30 PM EST - 1 year ago

10x Genomics Annual report: Q4 2024

Feb 12, 2025, 4:30 PM EST - 1 year ago

10x Genomics Earnings release: Q4 2024

Feb 12, 2025, 4:05 PM EST - 1 year ago

10x Genomics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Outlook for 2025

Feb 6, 2025, 8:30 AM EST - 1 year ago

Chan Zuckerberg Initiative Launches Billion Cells Project with 10x Genomics and Ultima Genomics to Advance AI in Biology

Feb 4, 2025, 8:59 AM EST - 1 year ago

Parse Biosciences Invalidates All 10x Genomics' Patent Claims Asserted Against Its Products

Jan 31, 2025, 6:34 AM EST - 1 year ago

Spatial Omics Research Report 2023-2034: Market to reach $1.09 Billion - 10x Genomics Enhances Spatial OMICS with New Visium Spatial Gene Expression for FFPE

Jan 28, 2025, 4:05 PM EST - 1 year ago

10x Genomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 12, 2025

Jan 13, 2025, 10:30 AM EST - 1 year ago

10x Genomics Transcript: 43rd Annual J.P. Morgan Healthcare Conference 2025

Jan 13, 2025, 10:30 AM EST - 1 year ago

10x Genomics Slides: FY 2025

Jan 2, 2025, 4:05 PM EST - 1 year ago

10x Genomics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Dec 23, 2024, 4:05 PM EST - 1 year ago

U.S. District Court Awards 10x Genomics Permanent Injunction in Patent Infringement Lawsuit Against Bruker Corporation's GeoMx Products

BRKR

Nov 19, 2024, 1:00 PM EST - 1 year ago

10x Genomics Transcript: Wolfe Research Healthcare Conference 2024

Nov 7, 2024, 4:05 PM EST - 1 year ago

10x Genomics to Present at the Wolfe Research 2024 Healthcare Conference

WAJeff Jul. 1 at 8:05 PM

$TXG Sold this at a breakeven like a dummy. It went past that $36 target in my earlier post

0 · Reply

WAJeff Jul. 1 at 8:04 PM

$TXG been on a tear

0 · Reply

WOLFSTREET Jul. 1 at 1:27 AM

$TXG soon, you too can enjoy the entire platform like I do. for now, let me break down what matters most.

0 · Reply

WOLFSTREET Jul. 1 at 1:26 AM

0 · Reply

WOLFSTREET Jul. 1 at 1:19 AM

$TXG $RACE TXG 40% straight UP from this post, you only need to be in one place to perform like this, and that is @WOLFSTREET , on my street, where CC rules to roads.

0 · Reply

strassburg Jun. 28 at 2:42 AM

$TXG I love this stock for the future. Slow build

0 · Reply

itrekntravel Jun. 26 at 7:54 PM

$TXG pop goes my TXG! 💥

0 · Reply

egcgfiend Jun. 26 at 2:05 PM

$PACB $TXG $ILMN AI + genomics = cure all disease and aging

0 · Reply

WalterWhite13 Jun. 24 at 4:21 PM

$TXG the ATERA platform will dominate everything spacial. The Platform does more and is better than the marketing team is saying. This will be up by $80 by end of year.

3 · Reply

MikeCaymanTrades Jun. 21 at 12:55 AM

$TXG - Massive broadening wedge from last April. 6.78 to 34.76

0 · Reply

seannystockrockets Jun. 18 at 6:14 PM

$TXG and $HIMS both look great and now around $35. looking for some big upside potnetial with market cooperation.

0 · Reply

egcgfiend Jun. 18 at 4:29 PM

$PACB $TXG

2 · Reply

egcgfiend Jun. 18 at 3:39 PM

$PACB Oh look, Nanopore still has fundamental, physically entrenched accuracy issues (they were a fraud and we always knew it) In Pilot Study, Oxford Nanopore Shows Promise for Rare Disease Testing but Misses Some CNVs : GOTHENBURG, Sweden – Researchers at University Medical Center Utrecht in the Netherlands have found that Oxford Nanopore's sequencing technology is promising for rare genetic disease testing, but still needs to improve its ability to correctly call diagnostically relevant copy number variants, along with better data visualization and quality control tools. $TXG 10x is rock solid tech and has a great future but it is apples to oranges with $PACB which will also run soon, once we shake off a few crusty short seller 'tards

0 · Reply

JMJTrading Jun. 17 at 1:52 PM

$GDHG all in here! Very bouncy! Should get some attn for being a micro float and primed to run to $TXG $PAVS $CRVO $OBAI

1 · Reply

JMJTrading Jun. 16 at 5:35 PM

$CRVO A new solid base was just formed at $5. This will launch into a reversal - Follow for more. SL at $4.98 - Sell at $TXG $SUGP $QTEX

0 · Reply

MorganHoratio Jun. 9 at 11:32 PM

During this market downturn, please pay attention to the following stocks: Health: $ABCL $VKTX $HIMS $TXG $CRSP An exceptional high-alpha radar for the healthcare sector! This local macro consolidation is providing a premium entry zone for true clinical disrupters and digital health compounders. The fundamental catalysts driving this group are deeply institutional. HIMS is a standout hyper-growth monster, surging over 6% into the $28 node backed by relentless expansion in its customized weight-loss workstreams and explosive net income inflections. VKTX represents an elite macro-accumulation play ahead of its critical oral obesity data milestones, while CRSP and TXG (10x Genomics) lock in structural, irreplaceable moats across gene-editing and spatial biology instrumentation. As capital rotates into high-conviction health tech, are you compounding shares in the immediate cash-flow powerhouse HIMS, or front-running the technical floors on VKTX and CRSP?

1 · Reply

WalterWhite13 Jun. 9 at 3:52 PM

$TXG

0 · Reply